Genetic variations in the DTNBP1 gene (encoding the protein dysbindin-1) have been implicated as risk factors in the pathogenesis of schizophrenia. Previous studies have indicated that dysbindin-1 functions in the regulation of synaptic activity. Recently, dysbindin-1 has also been documented to be involved in neuronal development. In this study, we identified necdin as a binding partner of dysbindin-1 using a yeast two-hybrid screen. Dysbindin-1 recruits necdin to the cytoplasm, thereby attenuating the repressive effects of necdin on p53 transcriptional activity. Knockdown of dysbindin-1, like knockdown of p53, greatly decreases the expressions of the p53 target genes coronin 1b and rab13, which are required for neurite outgrowth. Moreover, overexpression of p53 restores the neurite outgrowth blocked by dysbindin-1 knockdown. In brains of dysbindin-1 null mice (the sandy strain), p21, Coronin 1b and Rab13 levels are reduced. Furthermore, primary cultured cortical neurons from sandy mice display neurite outgrowth defects when compared with those from wild-type mice. Thus, our data provide evidence that dysbindin-1 has an important role in neurite outgrowth through its regulation of p53's transcriptional activity.
Introduction
Schizophrenia is a severe mental disorder that affects 0.5-1% of the population and has a strong hereditary component. 1 To date, many susceptibility genes have been found to be associated with schizophrenia by genetic studies. 2 Genetic variations in the DTNBP1 gene encoding dysbindin-1 have been linked to schizophrenia in multiple populations. [3] [4] [5] [6] Some of these genetic variations are associated with a decreased level of dysbindin-1 mRNA in the prefrontal cortex of schizophrenia patients. 7 In the hippocampus of schizophrenia patients, the protein levels of dysbindin-1 are significantly reduced. 8 Functional studies have revealed that genetic variations of DTNBP1 modulate prefrontal brain function 9 and contribute to impairments in spatial working memory and executive function. 10 These studies have shown a strong connection between dysbindin-1 function and the pathogenesis of schizophrenia.
Previous studies have shown that dysbindin-1 functions both pre-and postsynaptically through interaction with partners 11, 12 to regulate neurotransmitter release and signal transduction. Decreased dysbindin-1 expression is related to intrinsic glutamatergic alterations in the hippocampi of schizophrenia patients. 8 Furthermore, knockdown of endogenous dysbindin-1 in cultured cells leads to a decrease of glutamine release. 13 It has also been reported that knockdown of dysbindin-1 increases cell surface dopamine receptor (D2DR) levels, 14 and that a decrease of dysbindin-1 expression increases both the D2DR recycling rate and the rate of its insertion into cell surface. 15 Thus, loss of dysbindin-1 function may contribute to the pathogenesis of schizophrenia due to altered neurotransmitter signaling.
In addition to the role of neurotransmitters in the etiology schizophrenia, evidence for a defect in neurite formation during development caused by susceptibility gene products has been obtained. 16 Of these gene products, DISC1 (disrupted-in-schizophrenia-1) was reported to regulate neurite outgrowth during neuron differentiation 17, 18 and NRG1 (neuregulin-1) was reported to induce neurite formation. 19 The expression level of dysbindin-1 in the mouse brain is developmentally regulated, suggesting that dysbindin-1 may be involved in neuronal development. 11 Downregulation of dysbindin-1 by small interfering RNA in SH-SY-5Y cells causes shorter neurite length and aberrant organization of the actin cytoskeleton at the tips of neurites. 20 Primary hippocampal neurons derived from sandy mice, which lack dysbindin-1 protein due to the deletion of two exons in the DTNBP1 gene, 21, 22 exhibit abnormal cytoskeletal organization in the growth cone. 20 It was recently reported that dysbindin-1 regulates dendrite spine formation through its interaction with WAVE2 and Abi-1. 23 Moreover, dysbindin-1 is a subunit of the biogenesis of lysosome-related organelles complex-1, which is required for the trafficking of lysosomerelated organelles. 24 The dysbindin-1-containing biogenesis of lysosome-related organelles complex-1 is also involved in neurite outgrowth. 11 These studies highlight functions of dysbindin-1 in neurite outgrowth; however, the underlying mechanisms are still largely unknown.
As an established tumor suppressor protein, p53 binds to specific DNA sequences to transcriptionally regulate the expression of apoptosis-related proteins (such as bax and puma) when cells are exposed to apoptotic stressors. 25 Besides from its role in cell death, non-apoptotic functions of p53 are also required during neuronal development. 26 Recently, increasing evidence has shown that p53 transcriptional activity is critical for neurite outgrowth. In PC12 cells, p53 transcriptional activity is necessary for nerve growth factor (NGF)-mediated differentiation. 27 Moreover, two proteins that are transcriptionally activated by p53, the small GTPase Rab13 and the F-actin-binding protein Coronin 1b, are required for neurite outgrowth and nervous system regeneration. 28, 29 The effects of these two proteins on neurite outgrowth are dependent on p53 transcriptional activity. 28, 29 The p53 target protein cyclic guanosine monophosphate (cGMP)-dependent protein kinase type I, which influences growth cone navigation, was also reported to be regulated by p53 during neuronal maturation. 30 Thus, the regulation of multiple neuronal development-related proteins by p53 ensures neurite outgrowth until axon formation or maturation. 27, 29, 30 In addition, factors that influence p53 transcriptional activity can manipulate the fate of neurons. For example, Krü ppel-like factor-4, which was identified as a transcriptional repressor of p53, inhibits neurite outgrowth during central nervous system neuron development. 31 Here, we investigated the role dysbindin-1-mediated regulation of p53 activity in neurite outgrowth.
Materials and methods
Information about plasmid construction, yeast twohybrid screening, glutathione S-transferase pull-down assays, immunoprecipitation, antibodies, immunocytochemistry, RNA interference, reverse transcription-PCR assays, cell culture and transfection, and dual-luciferase reporter gene assays are provided in the Supplementary Materials and Methods.
Culture and transfection of primary cultured neurons Dissociated rat or mouse cortex cultures were prepared from postnatal 0-to 1-day-old Sprague-Dawley rats or C57BL/6J mice. Cortical cells were gently dissociated with a plastic pipette after digestion with 0.5% trypsin (GIBCO, Los Angeles, CA, USA) at 37 1C for 20 min. The dissociated cells were plated at a final density of 5 Â 10 5 cm À2 on polyethyleneimine-coated 24-well plates (Corning, Inc., Corning, NY, USA) and cultured in Neurobasal medium (GIBCO) containing 1 Â B27 supplement (GIBCO) and 3 mg ml À1 glutamine (Sigma, Saint Louis, MO, USA). After 3 days of culturing, 5-fluoro-2 0 -deoxy-uridine (FUDR) was added to a final concentration of 10 mM (Sigma) to repress the growth of glial cells.
For transfection, cultured cells were washed with Opti-MEM (GIBCO, Los Angeles, CA, USA) medium and then transfected with small interfering RNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) reagent in Opti-MEM medium without serum. Primary cell culture medium was added to the culture medium at 6 h after transfection. At 4 days after transfection, the cells were subjected to reverse transcription-PCR analysis.
Animal experiments
Sandy mutant (sdy/sdy) and wild-type (WT; þ / þ ) mice were derived from heterozygotes obtained from the Jackson Laboratory (Bar Harbor, ME, USA). To determine the genotypes of þ / þ , þ /sdy and sdy/ sdy, we performed PCR assays to genotype the mice based on the nature of the deletion mutation in the DTNBP1 gene. 22 The cortex and hippocampus of mouse brains were homogenized in cell lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40 and 0.5% sodium deoxycholate) in the presence of a protein inhibitor cocktail (Roche, Mannheim, Germany). The lysates were subjected to immunoblot analysis. For total RNA extraction, the hippocampus of mice was homogenized in lysis buffer using a protein and RNA extraction kit (Takata, Shiga, Japan), and total RNA was isolated according to the manufacturer's recommendations. All mice were maintained in a specific pathogen-free room, and all animal experiments were approved by the Animal Welfare Advisory Committee of the University of Science and Technology of China.
Statistical analysis
Relative density analysis of immunoblots and reverse transcription-PCR products from three independent experiments was performed using Adobe Photoshop CS 8.0 (Adobe, San Jose, CA, USA). Data were analyzed using Origin 7.5 (OriginLab, Northampton, MA, USA). 17, 29, 32 Each well was evaluated using three different fields under a microscope. The average neurite length of approximately 200-250 cells is presented as mean ± s.e. For cultured primary neurons, the cortical neurons from newborn C57BL/6J WT mice or sandy mice were used. These cells were cultured in NB/B27 (neurobasal medium containing 1 Â B27 and glutamine) medium for 5 days. Neurite analysis was performed using Image J software after cells were immunostained with anti-Tuj1 antibody. The length of the longest neurite of each neuron was measured from the edge of each soma to neurite tips. For each group, three independent experiments were performed. In each replicate, 100-110 cells were counted from several randomly selected microscope fields using an Â 40 objective. Relative average neurite lengths of B330 cells from three independent experiments were analyzed using OriginLab software and are presented as mean ± s.e. For soma size analysis, the soma area of each neuron was measured by Image J according to its user manual. The relative average soma areas of B300 cells from three independent experiments were analyzed using OriginLab software and are presented as mean ± s.e.
Neurite outgrowth assay

Results
Interactions between dysbindin-1 and necdin
To investigate dysbindin-1 function, a yeast twohybrid screen was performed to identify novel partners of dysbindin-1. Because full-length dysbindin-1 caused autoactivation in yeast strain AH109, 33 we used the N terminus of dysbindin-1 (amino acids 1-189) as the bait for a screen ( Figure 1a) . A total of 20 positive transformants were obtained, including snapin, homer1, 14-3-3 zeta, clusterin and a fragment of necdin containing amino acids 43-284. Snapin is a reported partner of dysbindin-1 12 and necdin is a protein associated with neuronal differentiation. 34 We therefore chose necdin for further study. To further confirm the necdin interaction with dysbindin-1 in yeast, we constructed a full-length version of activation domain (AD)-fused necdin and retransformed it into yeast with binding domain (BD)-dysbindin-1-(1-189) or BD vector. Yeast cotransformed with BDdysbindin-1-(1-189) and AD-necdin, as well as positive control yeast (cotransformed with BD-p53 and pTD1-1 that were supplied with the kit), grew well on culture medium lacking both histidine and adenine, indicating activation of each of the reporter genes, but negative control yeast (cotransformed with BD and AD vectors) or the yeast cotransformed with BD-dysbindin-1-(1-189) and AD vector did not ( Figure 1a ). These results suggest that dysbindin-1 interacts with full-length necdin in yeast.
To determine whether there is a direct interaction between necdin and dysbindin-1, we performed a glutathione S-transferase pull-down assay. Glutathione S-transferase-dysbindin-1, but not glutathione S-transferase alone, pulled down Hisnecdin (Supplementary Figure S1A) . To determine whether dysbindin-1 interacts with necdin in mammalian cells, we performed a coimmunoprecipitation assay in human embryonic kidney cells (HEK293A) expressing a combination of FLAG-dysbindin-1 and enhanced green fluorescence protein (EGFP) or necdin-EGFP. FLAG-dysbindin-1 coprecipitated with necdin-EGFP when necdin-EGFP was immunoprecipitated with anti-GFP antibodies; however, it did not precipitate with EGFP alone (Supplementary Figure S1B) . Similar results were obtained using antidysbindin-1 antibodies to immunoprecipitate endogenous dysbindin-1 in a neuroblastoma cell line (N2a cells) transfected with HA-necdin. When endogenous dysbindin-1 was immunoprecipitated, HA-necdin coprecipitated ( Figure 1b) .
Influence of dysbindin-1 on the intracellular distribution of necdin and p53 transcriptional activity Necdin was originally reported to be a nuclear protein, 35 but it was subsequently reported to localize to both the cytoplasm and the nucleus. 36, 37 We hypothesized that the interaction between dysbindin-1 and necdin might alter the cellular distribution of one or both proteins. To assess this possibility, we cotransfected HA-necdin together with EGFP or dysbindin-1-EGFP into HEK293A cells. HA-necdin appeared to be cytoplasmic in cells expressing dysbindin-1-EGFP, but it was diffusely distributed in both the cytoplasm and the nucleus in cells expressing EGFP (Figure 1c ) and in cells transfected with HA-necdin alone (data not shown).
Necdin was previously reported to interact with transcription factors, such as p53 and E2F1, in the nucleus and to have an important role during the terminal differentiation of neurons. 34, 38, 39 It suppresses the transcriptional activity of p53 by interacting with it. 38 We found that the cellular distribution of necdin is altered by dysbindin-1. We thus employed a dualluciferase assay to investigate whether dysbindin-1 influences p53 transcriptional activity. In human colon tumor cells that lack p53 (HCT116 p53À/À), overexpression of p53 greatly increased p53-responsive element-containing reporter activity to B18 times that of the basal level, and coexpression of necdin repressed p53 transcriptional activity. However, overexpression of dysbindin-1 significantly blocked the repressive effects of necdin on p53 transcriptional activity (Figure 1d ). To further confirm the effects of dysbindin-1 on p53 transcriptional activity, we tested whether dysbindin-1 increases endogenous p53 transcriptional activity. In a human colon tumor cell line with WT p53 (HCT116 Quantitative data from three independent experiments were quantified by one-way ANOVA, *P < 0.05. (e) Reporter gene assays similar to those in d using HCT116 p53-wild-type cells were performed to show the effects of dysbindin-1 or necdin on endogenous p53 activity. Quantitative data from three independent experiments were quantified by one-way ANOVA, *P < 0.05. (f) Reporter gene assays similar to those in d using HCT116 p53-null cells were performed to show that HAdysbindin-1 has no effect on p53 report genes without p53. Quantitative data from three independent experiments were quantified by one-way ANOVA, NS. NS, not significant. p53 þ / þ ), overexpression of dysbindin-1 increased endogenous p53 transcriptional activity over the basal level (Figure 1e ). However, simultaneous overexpression of necdin repressed endogenous p53 transcriptional activity, and these effects were partially blocked by overexpressing dysbindin-1 (Figure 1e) . Moreover, overexpressing HA-dysbindin-1 in HCT116 p53-null cells failed to increase p53 reporter activity (Figure 1f) , suggesting that dysbindin-1 cannot activate p53 reporter activity without p53.
To further explore the influence of dysbindin-1 on the transcriptional activation of p53, we next tested whether dysbindin-1 influences the expression of downstream target gene transactivated by p53. We examined p21, a well-known transcriptional target of p53. 40, 41 In HCT116 WT cells transfected with dysbindin-1, both the protein and the mRNA levels of p21 increased (Supplementary Figure S2A and B) . In contrast to dysbindin-1 overexpression, knockdown of endogenous dysbindin-1 decreased p21 levels in cells treated or not treated with doxorubicin, an inducer of p53 (Supplementary Figure S2C) . Moreover, in HCT116 p53-null cells cotransfected with p53-EGFP and FLAG or FLAG-necdin, along with or without HA-dysbindin-1 as indicated, necdin overexpression decreased both the protein and mRNA levels of p21 that had been induced by p53 overexpression. However, in the presence of dysbindin-1, necdin failed to repress p21 levels (Supplementary Figure S2D) , suggesting that dysbindin-1 influences the effects of necdin on p53 target gene expression.
Amino acids 97-118 of dysbindin-1 are required for its interaction with and effects on necdin To further identify which domain of dysbindin-1 is critical for its interaction with necdin, we generated several deletion mutants of dysbindin-1 (Figure 2a) . We already showed that amino acids 1-189 of dysbindin-1 interact with necdin in a yeast twohybrid screen (Figure 1a) , suggesting that dysbindin-1 may interact with necdin though its N terminus. To confirm this, we constructed an N terminus of dysbindin-1 containing amino acids 1-217 (dysbindin-1-N-EGFP) and a C terminus of dysbindin-1 containing amino acids 216-351 (dysbindin-1-C-EGFP). We then transfected HEK293A cells with FLAG-necdin together with either EGFP, EGFPtagged full-length dysbindin-1, dysbindin-1-N or dysbindin-1-C. Necdin coimmunoprecipitated with both EGFP-tagged full-length dysbindin-1 and dysbindin-1-N, but not with EGFP alone or EGFP-tagged dysbindin-1-C (Figure 2b) .
Amino acids 1-217 of dysbindin-1 contain a coiledcoil domain (CCD) located in amino acids 89-188 42 and a putative leucine zipper motif (LZM) in amino acids 97-118 that is predicted by PROSITE (http:// us.expasy.org/prosite/). We therefore generated two deletion mutants in which amino acids 89-188 or 97-118 were deleted (Figure 2a) . We transfected HEK293 cells with FLAG-necdin along with either EGFP, EGFP-tagged full-length dysbindin-1 or EGFP-tagged dysbindin-1 mutants and performed coimmunoprecipitation assays. In contrast to full-length dysbindin-1, which interacted with necdin, neither dysbindin-1DCCD-EGFP nor dysbindin-1-DLZM-EGFP interacted with necdin (Figure 2c ), suggesting that amino acids 97-118, the LZM of dysbindin-1, are critical for its interaction with necdin. To assess whether the LZM of dysbindin-1 (amino acids 97-118) are involved in the effects of dysbindin-1 on necdinmediated p53 transcriptional regulation, we performed dual-luciferase assays. In HCT116 p53-null cells, dysbindin-1-EGFP blocked the repressive effects of necdin on p53 transcriptional activity. However, dysbindin-1DLZM-EGFP did not ( Figure 2d ). As dysbindin-1DLZM-EGFP failed to regulate necdin-mediated repression of p53 activity, we next asked whether it had effects on the cellular distribution of necdin. We transfected HEK293A cells with HA-necdin along with EGFP-tagged full-length dysbindin-1 or dysbindin-1DLZM and examined the distribution of necdin using immunocytochemical staining. In contrast to full-length dysbindin-1, which caused a translocation of necdin from the nucleus to the cytoplasm, dysbindin-1DLZM-EGFP, similarly to EGFP, did not alter the subcellular distribution of necdin (Figure 2e ), suggesting that amino acids 97-118 are critical for the ability of dysbindin-1 to alter necdin's subcellular distribution. Taken together with the coimmunoprecipitation and reporter gene assay results (Figures 1 and 2 ), these data suggest that dysbindin-1 regulates transcriptional activity of p53 by altering the subcellular distribution of necdin through its LZM domain.
Regulation of downstream targets of p53 and neurite outgrowth by dysbindin-1 p53 is a well-known tumor suppressor; however, it was recently reported to be associated with neuronal differentiation. 27, 43 Multiple neural development-related genes have been found to be transcriptionally regulated by p53. For instance, the F-actin-binding proteins Coronin 1b and GTPase Rab13, two proteins critical for neurite outgrowth, are transcriptionally regulated by p53. 29 Importantly, dysbindin-1 was also reported to be involved in neurite outgrowth in cultured cells and primary neurons. 20 We thus wondered whether dysbindin-1 facilitates neurite outgrowth in a pathway similar to that of p53. We employed a mouse neuroblastoma cell line (N2a cells), a commonly used cell line whose differentiation and neurite outgrowth can be induced by retinoic acid or serum deprivation, 44, 45 as a model for neurite outgrowth assays. After induction with a low concentration of serum, the average neurite length was much shorter in p53 knockdown cells (Figure 3a) . Similar results were obtained in dysbindin-1 knockdown cells (Figure 3b ). Consistent with previous findings, 29 the mRNA levels of Coronin 1b and Rab13, two factors associated with neurite outgrowth, were significantly decreased in p53 knockdown cells treated with retinoic acid or low-concentration serum ( Figure 3c ). Interestingly, similar changes were observed in dysbindin-1 knockdown cells (Figure 3d) . Moreover, no alterations in p53 or necdin expression levels were observed when dysbindin-1 was knocked down (Supplementary Figure S3A) . Furthermore, overexpression of p53 restored the neurite outgrowth that was repressed by dysbindin-1 knockdown (Figure 3e ). Influence of dysbindin-1 on p53 target gene expression and neurite outgrowth To further explore the physiological roles of dysbindin-1 in p53 target gene expression, we examined Coronin 1b and Rab13 levels in primary cultured neurons and in sandy mice. In primary cultured neurons from rat cortex, knockdown of dysbindin-1 decreased both Coronin 1b and Rab13 mRNA levels (Figure 4a ). In sandy mice in which dysbindin-1 is not expressed, the mRNA levels of p21, Rab13 and Coronin 1b were significantly decreased (Figure 4b) . The protein levels of p21 in the hippocampi of sandy mice were also lower than in control mice (Figure 4c ). Moreover, we observed no alteration in the mRNA levels of p53 or necdin in dysbindin-1 knockdown primary cortical neurons or in sandy mice (Supplementary Figure S3B and C). Finally, to test the possibility that dysbindin-1 might influence neurite outgrowth in cultured primary neurons, we cultured cortical neurons derived from newborn WT mice or sandy mice (postnatal days 0 and 1) for neurite outgrowth. Cortical neurons from sandy mice showed shorter neurite lengths than WT mice after being cultured for 5 days (B24% decrease, P = 0.0088). Moreover, no alteration was observed in neuronal soma size between WT mice and sandy mice (Figure 4d and Supplementary Figure S4 ). These data reveal that dysbindin-1-deficient neurons have a defect in neurite outgrowth.
Discussion
In this study, we demonstrate a novel function of dysbindin-1, whereby it regulates p53 activity and subsequently influences neurite outgrowth. We demonstrate that dysbindin-1 upregulates p53 transcriptional activity to promote neurite outgrowth by interacting with necdin and recruiting it to the cytoplasm. Necdin is a member of the melanoma antigen-encoding gene family. 46, 47 It is predominantly expressed in postmitotic neurons and is associated with Prader-Willi syndrome, a neurodevelopmental disorder. 48, 49 Necdin has been identified as a multifunctional protein that interacts with and represses transcription factors such as E2F1 and p53 in the nucleus. 38, 50, 51 In our study, we found that dysbindin-1 interacts directly with necdin (Supplementary Figure S1A ). Dysbindin-1 overexpression results in necdin translocation to the cytoplasm (Figure 1c ). Because necdin functions in the nucleus to repress p53 transcriptional activity, recruitment of necdin to the cytoplasm by dysbindin-1 may cause necdin to fail to repress p53 transcriptional activity. Furthermore, evidence for the involvement of these interactions in the regulation of p53 transcriptional activity comes from observations that the repressive effects of necdin on p53 cannot be blocked by dysbindin-1DLZM-EGFP, a deletion mutant that neither interacts with necdin nor changes necdin's cellular distribution (Figures 2d and e ). These data demonstrate that dysbindin-1 upregulates p53 transcriptional activity by interacting with necdin and recruiting it to the cytoplasm ( Figure 5 ). Although p53 promotes the expression of many apoptosis-related proteins when cells are exposed to apoptotic stressors, a non-apoptotic role of p53 in neuronal development has also been proposed. It has been well documented that p53 can act as either an apoptotic or non-apoptotic factor based on its posttranscriptional modification pattern. 26 In our experimental system, overexpression of p53 in N2a cells failed to induce cell death in either normal or differentiation conditions (Supplementary Figure  S5) , because the cells were not exposed to apoptotic stressors. Moreover, it has been well documented that there is a tissue-specific restriction of the p53 response. 52, 53 Furthermore, high levels of p53 mRNA are present in some areas in the developing brain, but the cells do not undergo p53-dependent apoptosis. 54, 55 Interestingly, in p53-deficient mice, defects of the neural tube have been observed, 56 indicating that p53 has non-apoptotic functions during neural development.
We observed that dysbindin-1 knockdown, similarly to p53 knockdown, represses neurite outgrowth. p53 overexpression restores neurite outgrowth in dysbindin-1 knockdown cells (Figure 3 ). These data suggest that dysbindin-1 functions in the p53 pathway to regulate neurite outgrowth. In vivo studies further show that the mRNA levels of Coronin 1b and Rab13, two p53 target genes, are both downregulated in sandy mice (Figure 4b) . Furthermore, cortical neurons of sandy mice display neurite outgrowth defects compared with those of WT mice (Figure 4d ). Taken together, we propose that dysbindin-1 may activate p53 by attenuating necdin repression, allowing the maintenance of p53 transcriptional activity and the gene expression necessary for neurite outgrowth.
It has been reported that Rab13 promotes neurite outgrowth by interacting with and counteracting neurite outgrowth inhibitors. 57 Depletion of Coronin 1b from cells alters lamellipodial dynamics due to increased actin filament nucleation in the leading edge. 58 Interestingly, in cultured hippocampal neurons from sandy mice, there is a derangement of actin RT-PCR assays were performed to show that the mRNA levels of p21, Coronin 1b and Rab13 are all lower in the hippocampi of sandy mice than in those of wild-type (WT) mice of the same age. Densitometric data from three independent experiments were quantified by one-way ANOVA, *P < 0.05. (c) Immunoblot analyses were performed to show that p21 protein levels are lower in the hippocampi of sandy mice than in those of WT mice of the same age. Densitometric data from three independent experiments were quantified by one-way ANOVA, *P < 0.05. (d) Representative image of cortical neurons from WT mice (C57BL/6J) and dysbindin-1-deficient sandy mice in NB/B27 (neurobasal medium containing 1 Â B27 and glutamine) medium for 5 days. Neurons were immunostained with anti-Tuj1 antibody (an anti neuron-specific class III b-tubulin antibody) to show neurons (red) and Hoechst to show nuclei (blue). The bar graphs show the relative average neurite length of B330 neurons from WT or sandy mice from three independent experiments (WT is 100%, bar: 10 mm, *P < 0.05, one-way ANOVA).
filaments in the growth cone and an abnormality of neurite morphogenesis. 20 In this study, we show that dysbindin-1 knockdown reduces the expression of both Rab13 and Coronin 1b (Figure 3d ). It is notable that the expression of dysbindin-1 is developmentally regulated in association with biogenesis of lysosomerelated organelles complex-1 during neuronal development. 11 It is therefore possible that the regulation of these two gene products by dysbindin-1 has an important role in neurite outgrowth during neuronal development. Further studies on the correlation between dysbindin-1 and p53 target gene products necessary for neurite outgrowth during brain development would contribute to our understanding of the detailed functions of dysbindin-1.
Recently, multiple lines of evidence have suggested that neuronal developmental events may be involved in the pathogenesis of schizophrenia. 59 Several susceptibility genes for schizophrenia, 16 including DISC1, 17,18 NRG1 19 and Akt, 60 are tightly associated with neuronal development. In postmortem brains of schizophrenia patients, spine density is lower than in normal controls. 59 In primary cultured neurons, knockdown of dysbindin-1 results in abnormal dendritic spine formation, 23 suggesting an involvement of dysbindin-1 in neuronal development. Our study shows the involvement of dysbindin-1 in neurite outgrowth through the p53 pathway, providing a mechanistic explanation for the association of dysbindin-1 with neuronal development. Thus, a decrease in dysbindin-1 protein in schizophrenia patients may lead to susceptibility to illness through abnormal development of the neural system.
In conclusion, this study reveals a novel function of dysbindin-1 in association with neurite outgrowth. Figure 5 A diagram summarizing our findings: recruitment of necdin to the cytoplasm by dysbindin-1 promotes p53 transcriptional activity when cells undergo differentiation. This increased p53 transcriptional activity promotes the expression of neurite outgrowth-related genes (coronin 1b and rab13), which in turn induce neurite outgrowth.
